These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2653670

  • 1. Limitation of the alpha-methylnorepinephrine hypothesis in the hypotensive effect of alpha-methyldopa.
    Tung CS, Chen SZ, Hsu CH, Tseng CJ.
    Clin Exp Hypertens A; 1989; 11(1):45-58. PubMed ID: 2653670
    [Abstract] [Full Text] [Related]

  • 2. Depletion of brainstem epinephrine stores by alpha-methyldopa: possible relation to attenuated sympathetic outflow.
    Tung CS, Goldberg MR, Hollister AS, Sweetman BJ, Robertson D.
    Life Sci; 1988; 42(23):2365-71. PubMed ID: 3287081
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive metabolites of alpha-methyldopa.
    Robertson D, Tung CS, Goldberg MR, Hollister AS, Gerkens JF, Oates JA.
    Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
    [Abstract] [Full Text] [Related]

  • 4. [Alpha-methyldopa and brain monoamines].
    Niwa M, Kawano T, Fujita Y, Maemura S, Ozaki M.
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):451-9. PubMed ID: 6813206
    [Abstract] [Full Text] [Related]

  • 5. Central and peripheral cardiovascular effects of alpha-methylepinephrine.
    Tung CS, Goldberg MR, Hollister AS, Oates JA, Robertson D.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth.
    Altura BM.
    Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755
    [Abstract] [Full Text] [Related]

  • 7. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ, Conway E, Summers R, Beart P, Jarrott B.
    Hypertension; 1984 Jun; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [Abstract] [Full Text] [Related]

  • 8. Evidence that alpha-methylepinephrine is an antihypertensive metabolite of alpha-methyldopa.
    Goldberg MR, Tung CS, Ring M, Oates JA, Gerkens JF, Robertson D.
    Clin Exp Hypertens A; 1982 Jun; 4(4-5):595-604. PubMed ID: 7105433
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
    Freed CR, Wang CH, U'Prichard DC.
    Hypertension; 1984 Jun; 6(5 Pt 2):II34-9. PubMed ID: 6094347
    [Abstract] [Full Text] [Related]

  • 11. Relationships between the cardiovascular effects of alpha-methyldopa and its metabolism in pontomedullary noradrenergic neurons of the rabbit.
    Bobik A, Oddie C, Scott P, Mill G, Korner P.
    J Cardiovasc Pharmacol; 1988 May; 11(5):529-37. PubMed ID: 2455838
    [Abstract] [Full Text] [Related]

  • 12. alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors.
    Clineschmidt BV, Flataker LM, Faison EP, Haubrich DR.
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):231-43. PubMed ID: 6250499
    [Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatographic analysis of norepinephrine and alpha-methylnorepinephrine in microdissected noradrenergic cell groups of the rabbit brain.
    Oddie CJ, Mill GK, Scott PJ, Bobik A.
    J Chromatogr; 1986 Dec 19; 383(2):307-16. PubMed ID: 3549749
    [Abstract] [Full Text] [Related]

  • 14. Direct evidence for imidazoline (I1) receptor modulation of ethanol action on norepinephrine-containing neurons in the rostral ventrolateral medulla in conscious spontaneously hypertensive rats.
    Li G, Abdel-Rahman AA.
    Alcohol Clin Exp Res; 2007 Apr 19; 31(4):684-93. PubMed ID: 17374048
    [Abstract] [Full Text] [Related]

  • 15. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs.
    Li G, Wang X, Abdel-Rahman AA.
    J Cardiovasc Pharmacol; 2005 Jul 19; 46(1):52-62. PubMed ID: 15965355
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.
    Mwaluko G, Weinshilboum R.
    Br J Clin Pharmacol; 1982 Aug 19; 14(2):231-9. PubMed ID: 7049213
    [Abstract] [Full Text] [Related]

  • 18. Lack of involvement of the kallikrein-kinin system in the depressor effect of alpha-methyldopa in normotensive rats.
    Lebrun FL, Lebrun I, Corrêa FM.
    Gen Pharmacol; 1994 Jul 19; 25(4):747-52. PubMed ID: 7958737
    [Abstract] [Full Text] [Related]

  • 19. Formation of alpha-methylnorepinephrine as a metabolite of metaraminol in guinea pigs.
    Fuller RW, Snoddy HD, Perry KW, Bernstein JR, Murphy PJ.
    Biochem Pharmacol; 1981 Oct 19; 30(20):2831-6. PubMed ID: 7032527
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.
    Bobik A, Jennings G, Jackman G, Oddie C, Korner P.
    Hypertension; 1986 Jan 19; 8(1):16-23. PubMed ID: 3943883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.